Choksi Asia Limited (CHOKSI) Share Price

BSE · Healthcare · Medical Devices · ISIN INE865B01016

₹250.00+7.00 (+2.88%)

Key metrics

Market Cap
₹143 Cr
P/E Ratio
27.29
EPS
9.16
Book Value
73.85
P/B Ratio
3.39
ROE
12.67%
ROCE
14.82%
Debt / Equity
0.05
Net Margin
10.82%
Revenue Growth
33.34%
Profit Growth
72.12%
Dividend Yield
52W High
₹266.45
52W Low
₹75.00
Market Cap Band
micro cap
Face Value

Ratios computed from the annual results period ending 2026-03-31.

About Choksi Asia Limited

Choksi Asia Limited primarily engages in the manufacture and sale of photosensitized materials and other products for the healthcare industry in India. It sells X-Ray films, lead screens, chemicals, radiation shielding materials, X-Ray generator, radiography camera, radioactive Sources and trading of other related accessories. The company also provides X-ray films and chemicals, which include laser green, laser blue, and laser chemical products; X-ray accessories, comprising screens, cassettes, illuminators, and aprons; and laser NDT chemicals for processing industrial X-ray film. In addition, it trades in specialty x-ray films and medical equipment. The company was formerly known as Choksi Imaging Limited and changed its name to Choksi Asia Limited in April 2025. Choksi Asia Limited was incorporated in 1992 and is based in Mumbai, India.

Headquarters
Mumbai, India
Promoter Holding
80.27%

The full Choksi Asia Limited analysis

Create a free account to open the complete CHOKSI deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.

  • 10-year financialsIncome statement, balance sheet and cash flow, year by year.
  • Valuation & fair valueFair-value estimates, quality scores and a value grade.
  • Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
  • Shareholding historyPromoter, FII, DII and public holdings across every quarter.
  • Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
  • Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.